Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OCTRU is running a one-day course for those wishing to be a chief investigator on the design and conduct of clinical trials on Friday 10th June 2016 at the Botnar Research Centre.

The Oxford skyline

Aim: To provide those wishing to be a chief investigator with a greater understanding of how to design and conduct their own clinical trial and the secrets of a successful funding application.


Course objectives:

  • To understand how to develop a good research question
  • To explore the principles of good trial design
  • To know where to apply for trial funding
  • To understand how to write a successful funding application
  • To know how to effectively cost a trial
  • To understand the role of a Clinical Trials Unit


Venue: Botnar Research Centre, University of Oxford, Windmill Road, Oxford, OX3 7LF

Target audience: This course is specifically targeted at new investigators who would like to design and conduct their own trial but who have not yet successfully applied for funding.

Cost: £75 

CPD Credits: Approved by the Federation of the Royal College of Physicians for 5 category 1 (external) CPD credit(s)


Please note places are limited. Please email for further details.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.